Ranitidine
- TRADE NAMES: Apo-Ranitidine; Axoban; Azantac; Nu-Ranit; Raniben; Raniplex; Ranisen; Sostril; Zantab; Zantac (Concordia); Zantac-C; Zantic
- INDICATIONS: Duodenal ulcer
- CLASS: Histamine H2 receptor antagonist
- HALF-LIFE: 2.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acalabrutinib, Alfentanil, Delavirdine, Fentanyl, Gefitinib, Lemborexant, Metformin, Prednisone, Rilpivirine, Risperidone
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
